NCBiotech News

Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, has received U.S. Food and Drug Administration approval of Duaklir Pressair, a maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

Three North Carolina life science innovators strongly recommend others follow their lead and seek out the many resources provided by NCBiotech.

Durham-based Hatteras Venture Partners has completed a first closing of $94 million on a new investment fund that it hopes will reach $200 million.

The Research Triangle region hosts a growing ag tech industry as it combines history and innovation, draws on both urban and rural resources, and thrives on partnerships among private companies, government and academic institutions.

Asklepios BioPharmaceutical, (AskBio), a Research Triangle Park platform company playing a key role in North Carolina’s global gene therapy leadership, got a $235 million vote of confidence today.

Durham-based Mycovia Pharmaceuticals, a developer of drugs in women’s health, has shown that its oral drug candidate VT-1598 is active against Candida auris, an emerging multi-drug resistant fungal pathogen that presents a serious global health threat.

Speakers at an NCBiotech forum say personalized medicine is finally here to stay. And, driven by recent advances in genomics and lower genetic testing and sequencing costs, it’s transforming healthcare as we know it.

FHI 360, a Durham-based international nonprofit human development organization, has launched a subsidiary called FHI Clinical as a full-service contract research organization to manage complex clinical research in resource-limited settings around the world.

Wake Forest Baptist Health and Wake Forest School of Medicine in Winston-Salem have signed a memorandum of understanding with Atrium Health to create a medical school campus in Charlotte.

Triad BioNight 2019, an event showcasing bioscience growth and honoring industry leaders in the Piedmont Triad region, is scheduled for June 20 at the Grandover Resort and Conference Center in Greensboro.

Fresenius Kabi, a global health care company based in Germany, hosted a topping off ceremony last week to celebrate the $100 million expansion of its pharmaceutical manufacturing campus in Wilson.

HemoSonics -- a Charlottesville, VA-based business with R&D and manufacturing operations in Durham -- is about to expand after receiving FDA marketing authorization for its Quantra Hemostasis platform for use during cardiac and major orthopedic surgeries.

CiVentiChem, a pharmaceutical contract development and manufacturing company with international headquarters in Cary, has been purchased by Sterling Pharma Solutions, a British company in the same business.

A Thermo Fisher facility in Greenville that has become one of North Carolina’s largest pharmaceutical manufacturers, is getting another $74 million upgrade to support the growing global demand for biomanufacturing services and biologics products.

Alexandria Real Estate Equities Inc., an urban office REIT focused on collaborative life science and technology campuses, has officially opened the Alexandria Center for AgTech – Research Triangle, and has begun its second phase development.